Breakthrough drugs and treatments are giving new hope for slowing
neurodegenerative diseases like Alzheimer’s disease and ALS. But if
that progress slows, the societal and economic cost to the U.S. could
be high.
On January 31, POLITICO will convene lawmakers, officials, and
experts to discuss the path forward for better collaboration among
health systems and industry, the risks and benefits and what new
opportunities are emerging to improve early diagnosis, treatments and outreach to underrepresented communities.
Doors open at 5:00 PM ET. Programming will be followed by a reception with cocktails and passed hors d'oeuvres.
Upon entry, attendees will need to show a valid form of government issued ID.
